CASDIN CAPITAL
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management.
CASDIN CAPITAL
Industry:
Biotechnology Financial Services Life Science
Founded:
2012-01-01
Status:
Active
Contact:
+1 212 897 5430
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Lux Capital
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Social Starts
Social Starts is a venture capital partnership that focuses on the emerging science of individual health.
Syno Capital
Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.
Third Point Ventures
Third Point Ventures is an investment firm that focuses on enterprise, fintech, mobile, and healthcare innovation.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | LetsGetChecked | Casdin Capital investment in Series D - LetsGetChecked | 20 M USD |
| 2022-08-02 | Idrx | Casdin Capital investment in Series A - Idrx | 122 M USD |
| 2022-07-20 | Auron Therapeutics | Casdin Capital investment in Series A - Auron Therapeutics | 48 M USD |
| 2022-05-17 | Character Biosciences | Casdin Capital investment in Series A - Character Biosciences | 18 M USD |
| 2022-05-17 | Remix Therapeutics | Casdin Capital investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-05-10 | MOMA Therapeutics | Casdin Capital investment in Series B - MOMA Therapeutics | 150 M USD |
| 2022-05-10 | Invetx | Casdin Capital investment in Series B - Invetx | 60.5 M USD |
| 2022-03-29 | Arzeda | Casdin Capital investment in Series B - Arzeda | 33 M USD |
| 2022-03-24 | Celsius Therapeutics | Casdin Capital investment in Series B - Celsius Therapeutics | 83 M USD |
| 2022-03-22 | InnoSIGN | Casdin Capital investment in Series A - InnoSIGN | 7.33 M EUR |